From: Hepatitis B virus infection and development of chronic kidney disease: a cohort study
Ā | No. of incident cases (person-years) | Model 1 HR (95% CI) | Model 2 HR (95% CI) | Model 3 HR (95% CI) |
---|---|---|---|---|
eGFRā<ā60āml/min/1.73m2 or proteinuria | Ā | Ā | Ā | Ā |
HBsAg (ā) | 13,315 (1,608,299.2) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
HBsAg (+) | 609 (65,401.8) | 1.07 (0.99ā1.16) | 1.09 (1.00ā1.18) | 1.11 (1.03ā1.21) |
eGFRā<ā60āml/min/1.73m2 | Ā | Ā | Ā | Ā |
HBsAg (ā) | 3106 (1,641,700.4) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
HBsAg (+) | 119 (67,044.5) | 0.91 (0.76ā1.09) | 0.87 (0.72ā1.05) | 0.89 (0.73ā1.07) |
Proteinuria | Ā | Ā | Ā | Ā |
HBsAg (ā) | 10,560 (1,621,635.3) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
HBsAg (+) | 512 (65,806.8) | 1.17 (1.07ā1.28) | 1.20 (1.10ā1.31) | 1.23 (1.12ā1.35) |